1. Young male cancer survivors with low-normal serum morning total testosterone benefited from testosterone treatment as a therapeutic option to ...
1. The β-chain constant region of the T cell receptor (TCR) was targeted to specifically eliminate a population of malignant ...
1. Patients with refractory diffuse large B-cell or follicular lymphoma demonstrated high rates of remission when treated with anti-CD19 directed ...
1. Patients with mantle cell lymphoma treated with autologous stem cell transplantation experienced greater overall, event-free, and progression-free survival when ...
Complete Dissection or Observation for Sentinel-Node Metastasis in Melanoma The pathological status of the sentinel node, gathered via biopsy, is ...
1. Induction therapy and maintenance therapy for mantle-cell lymphoma with lenalidomide plus rituximab was found to be effective and safe. 2. ...
1. Contrast-enhanced CT results were weakly predictive of progression-free survival in follicular lymphoma patients after rituximab chemotherapy treatment. 2. Negative ...
1. New guidelines from the 11th and 12th International Conferences on Malignant Lymphoma emphasize the use of FDG-PET scans in ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.